The same is not true for Black women, who are 40% more likely to die from breast cancer than white women, suggesting other factors are to blame.
White women with breast cancer in deprived neighborhoods have a 47% increased risk of breast cancer mortality in compared with Black women living in the same areas, the results of a study recently published in JAMA Network Open show. Researchers believe this may be because even though White women gain more from socioeconomic advancements, they lose more when they are removed.
A team of researchers led by Lauren E. Barber, Ph.D., a postdoctoral fellow in the epidemiology department at Emory University Rollins School of Public Health, used the Georgia Cancer Registry to identify 36,795 patients with breast cancer living in Georgia diagnosed between 2010 to 2017. Of those patients, 11,044 (30.0%) were Black women and 25,751 (70.0%) were White women. Just over half had private health insurance. The average age of diagnosis in both groups was 60.3 years old. By the end of the study, 1,214 Black women had died, and 1,728 White women died.
A neighborhood was deemed as deprived using eight characteristics including the percentage of: individuals living under the federal poverty line, households receiving public assistance and female-headed households with children under the age of 18. These neighborhoods typically have litter, noise and air pollution, dilapidated buildings and a lack of green spaces.
Deprived neighborhoods may impact health because it increases exposure to chronic stress which leads to inflammation in the body, potentially contributing to a lowered immune system. These are thought to be critical pathways to breast cancer progress.
Breast cancer is currently the second leading cause of death in women in the United States. Historically, Black women are 40% more likely to die from breast cancer than White women. The contradictory findings of this study may be linked to other factors in Black communities such as an the food environment, crime rates and access to healthcare facilities, all of which were not included in this study.
“Neighborhood racial composition, residential mobility, and rurality did not explain the lack of association among non-Hispanic Black women, suggesting that factors beyond those explored here may contribute to breast cancer mortality in this racial group,” Barber writes. “Literature examining the association between neighborhood deprivation and breast cancer mortality according to race is sparse, but growing.”
How Financial Toxicity Screening Can Be Incorporated Into Everyday Healthcare in America
November 15th 2024Breast cancer treatment settings prove to be a good opportunity to talk about financial toxicity. These conversations can also happen in generalized healthcare, according to Laila Gharzai, M.D., LLM, from the Department of Radiation Oncology at Northwestern University.
Read More
Breast Cancer Patients Desire Early, Frequent Financial Screening
November 11th 2024Current financial screening procedures in the United States may need to change, according to recent research done by Laila Gharzai, M.D., LLM, from the Department of Radiation Oncology at Northwestern University.
Read More
Patient Advocacy Groups and Caretaker Diversity in Metastatic Breast Cancer Research
October 22nd 2024Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute and author of Investigating the Salience of Clinical Meaningfulness and Clinically Meaningful Outcomes in Metastatic Breast Cancer Care Delivery, shares the reasons why she chose to study metastatic breast cancer patients.
Read More
Differences in Defining 'Clinically Meaningful' in Metastatic Breast Cancer Care
October 4th 2024Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute, explains the importance of the term “clinically meaningful” and shares some of the ways it can be defined.
Read More